UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Helixmith’s antibody therapy shows efficacy in immunoglobulin kidney disease
by Shim Hyun-tai
2020-08-26 17:47
Celltrion to begin P1 trial of antibody-drug on mild Covid-19 patients
by Shim Hyun-tai
2020-08-26 17:17
HK inno.N, T&R Biofab to develop skin therapy using 3D tech
by Shim Hyun-tai
2020-08-26 16:19
Virus cases rebound above 300, pushing nation closer to tightest restrictions
by Shim Hyun-tai
2020-08-26 13:35
CrystalGenomics’ anticancer candidate has FDA’s orphan drug status
by Shim Hyun-tai
2020-08-25 17:07
라인
PharmAbcine, Samsung Biologics sign CDMO deal for antibody candidate
by Shim Hyun-tai
2020-08-25 16:57
Huons' eye drop wins Saudi’s regulatory nod
by Shim Hyun-tai
2020-08-25 14:50
New virus cases below 300 for 2nd day but spreads continue
by Shim Hyun-tai
2020-08-25 11:51
HK inno.N publishes P3 trial results of drug on gastric ulcers
by Shim Hyun-tai
2020-08-24 18:02
Intron Bio secures new drug substance for bacterial pneumonia
by Shim Hyun-tai
2020-08-24 18:01
라인
Regulator OKs Pfizer’s cardiomyopathy drug Vyndamax
by Shim Hyun-tai
2020-08-24 16:12
Genexine begins global P3 trial of anemia drug
by Shim Hyun-tai
2020-08-24 16:12
Despite fall in new virus cases, calls rise for tightest social distancing
by Shim Hyun-tai
2020-08-24 15:42
Korea at crossroads of nationwide epidemic, expands tighter restrictions to whole country
by Shim Hyun-tai
2020-08-22 19:08
Seoul using near 80% of Covid-19 sickbeds
by Shim Hyun-tai
2020-08-21 18:10
라인
Korea going all out to import, develop Covid-19 vaccines, treatments
by Shim Hyun-tai
2020-08-21 16:06
Daewoong to co-develop esophagitis drug for treating Covid-19
by Shim Hyun-tai
2020-08-20 18:41
Korea speeds up developing coronavirus-related products
by Shim Hyun-tai
2020-08-20 17:58
Three-digit daily viruses for a week, raising fears about 2nd round
by Shim Hyun-tai
2020-08-20 14:56
SNUBH team finds gene mutation causing stomach cancer within families
by Shim Hyun-tai
2020-08-19 21:10
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top